ZCMD (ZCMD) Stock Analysis
Verdict: AVOID
Severe revenue contraction and chronic operating loss overshadow balance sheet cash, making ZCMD a speculative value trap.
Investment score: 21/100
Zhongchao Inc is a micro-cap Chinese healthcare information provider suffering from a 28.3% top-line revenue decline, deep operating losses (-54.43% margin), and severe share price destruction (-99.9% off 52-week high).
Peers
| Peer | P/E | P/B | P/S | EV/EBITDA | ROIC % | Net margin % |
|---|---|---|---|---|---|---|
| JDZG | -2.09 | 0.02 | 0.74 | -0.07 | — | -0.41 |
| YQ | -2.21 | 0.96 | 0.94 | 1.98 | — | -0.46 |
| EDTK | -1.80 | 2.24 | 1059.48 | -8.61 | — | -601.36 |
| NAMI | -1.10 | 0.98 | 0.14 | -0.21 | — | -0.23 |
| WAFU | -5.96 | 0.65 | 1.03 | 3.24 | — | -0.17 |